Using the Neuroadaptagen KB200z™ to Ameliorate Terrifying, Lucid Nightmares in RDS Patients: the Role of Enhanced, Brain-Reward, Functional Connectivity and Dopaminergic Homeostasis

Abstract

BackgroundLucid Dreams are a form of dream life, during which the dreamer may be aware that he/she is dreaming, can stop/re-start the dreams, depending on the pleasantness or unpleasant nature of the dream, and experiences the dream as if he/she were fully awake. Depending on their content, they may be pleasant, un-pleasant or terrifying, at least in the context of patients, who also exhibit characteristics of Reward Deficiency Syndrome (RDS) and Posttraumatic Stress Disorder (PTSD).Case SeriesWe present eight clinical cases, with known substance abuse, childhood abuse and diagnosed PTSD/RDS. The administration of a putative dopamine agonist, KB200Z™, was associated with the elimination of unpleasant and/or terrifying, lucid dreams in 87.5% of the cases presented, whereas one very heavy cocaine abuser showed a minimal response. These results required the continuous use of this nutraceutical. The lucid dreams themselves were distinguishable from typical, PTSD nightmares insofar as their content did not appear to reflect a symbolic rendition of an originally-experienced, historical trauma. Each of the cases was diagnosed with a form of RDS, i.e., ADHD, ADD, and/or Tourette’s syndrome. They all also suffered from some form of Post-Traumatic-Stress-Disorder (PTSD) and other psychiatric diagnoses as well.ConclusionThe reduction or elimination of terrifying Lucid Dreams seemed to be dependent on KB220Z, whereby voluntary stopping of the agent results in reinstatement of the terrifying non-pleasant nature of the dreams. Following more required research on a much larger population we anticipate confirmation of these seemingly interesting observations. If these results in a small number of patients are indeed confirmed we may have found a frontline solution to a very perplexing and complicated symptom known as lucid dreams.

Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With “Dopamine Homeostasis” in Reward Deficiency Syndrome (RDS)

“…The latter effect may suggest an important brain mechanism called “neuroplasticity.” While the authors have, to date, published two papers showing that KB220z eliminates life-long, frequently terrifying lucid dreams, our most recent findings show a prolonged effect of KB220Z in the elimination of these nightmares, and potential conversion to happy lucid dreams up until 12 months. These clinical findings suggest the possibility of KB220Z-induced for neuroplasticity (McLaughlin, Blum, Oscar-Berman, Febo, Agan, et al, 2015; McLaughlin, Blum, Oscar-Berman, Febo, Demetrovics, et al, 2015). …”

Neurobiology of KB220Z-Glutaminergic-Dopaminergic Optimization Complex [GDOC] as a Liquid Nano: Clinical Activation of Brain in a Highly Functional Clinician Improving Focus, Motivation and Overall Sensory Input Following Chronic Intake

“…In terms of positive sleep aspects, earlier studies have shown that KB220Z can actually improve sleep [ 52 ] and even eliminate posttraumatic stress disorder (PTSD)/ADHD induced unwanted terrifying lucid dreams [ 53 – 54 ]. Along these lines, qEEG studies utilizing KB220Z has revealed reduced widespread theta activity with concomitant increase in both alpha and low beta waves in abstinent psychostimulant abusers [ 37 ] as well as in alcoholics and heroin addicts [ 38 ].…”

Pro-dopamine regulator, KB220Z, attenuates hoarding and shopping behavior in a female, diagnosed with SUD and ADHD

“…She also noted increased “mental energy;” during this time, she took the KB220Z. Later, she reported that she no longer had lucid dreams, despite having stopped the KB220Z 2 years prior ( McLaughlin, Blum, Oscar-Berman, Febo, Agan, et al., 2015 ; McLaughlin, Blum, Oscar-Berman, Febo, Demetrovics, et al., 2015 ; McLaughlin et al., 2016 ).…”